Cipla gets nod to raise funds

22 May 2018 Evaluate

Cipla has received an approval for raising funds up to Rs 2000 crore by issue of equity shares or American depository receipts or global depository receipts or foreign currency convertible bonds or other securities /financial instruments, whether denominated in Indian Rupee and/or foreign currency (ies), though a public issue or a private placement in accordance with the provisions of the applicable law. The Board of Directors of the company at their meeting held on May 22, 2018, approved the same.

The Board also gave approval  for raising funds up to Rs 2000 crore by issue of non-convertible debentures (in form of bonds or otherwise) or bonds, whether denominated in Indian Rupee and/or foreign currency(ies), though a public issue or a private placement in accordance with the provisions of the applicable law.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1466.05 -0.10 (-0.01%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×